 "Miracle cures to fake testing kits: UK clamps down on bogus Covid-19 drugs")
British authorities said on Saturday they were clamping down on bogus cures for the coronavirus, which currently has no specific licensed treatment.
The Medicines and Healthcare products Regulatory Agency (MHRA) said it was investigating 14 fake or unlicensed products to treat Covid-19, the respiratory disease caused by the coronavirus. So far 3,605 Britons have died from the coronavirus, the latest data show, and experts have said deaths will continue to rise until the effect of recent lockdown measures filter through and slow the spread of the disease in the coming weeks.
MHRA said it was investigating fake self-testing kits, miracle cures and so-called “anti-viral misting sprays”. “Don’t be fooled by online offers for medical products to help prevent or treat Covid-19,” Lynda Scammell, MHRA enforcement official said.
“There is no medicine licensed specifically to treat or prevent Covid-19, therefore any claiming to do so are not authorised and have not undergone regulatory approvals required for sale on the UK market.”
One subscription. Two world-class reads.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%